Collaboration Between SynCore Biotechnology Co., Ltd...
2015-01-31
Age-related macular degeneration is a common retinal disease characterized by degenerative visual acuity and eventual vision lo... more

SynCore Biotechnology Co., Ltd. held the Investor Co...
2014-11-07
SynCore Biotechnology Co., Ltd. held the Investor Conference at Shangri-La’s Far Eastern Plaza Hotel on 2nd October befor... more

The common stock of SyncoreBio Corp. (stock code: 41...
2014-11-07
SynCore Biotechnology (stock code: 4192) was public listed on October 28, 2014. The SynCore team led by the company’s Cha... more

SB05 CTA (Investigational New Drug) for Phase III cl...
2014-02-05
SynCroe has submitted the CTA into Belgium's Federal Agency for Medicines and Health Products(FAMHP) &n... more

SynCoreBio earns the Certificate of The 10th Nationa...
2013-12-19
Congratulations!! "Development of a novel small anticancer drug SB01 in Phase I clinical trial" of SynCoreBio is award... more